SMALLEST DES. BIG POSSIBILITIES. RESOLUTE ONYX™ 2.0-mm DES

Table showing image of Resolute Onyx and listing features and benefits.

RESOLUTE

ONYX DES

THE NEXT GREAT ADVANCEMENT IN ACUTE DES PERFORMANCE

Image showing low crossing profile of Resolute Onyx DES.

LOWEST CROSSING PROFILE1

FOR SUPERIOR DELIVERABILITY:

  • Lowest stent crossing profile — less than 1 mm
  • Superior deliverability for navigating challenging cases

     
LEARN MORE ABOUT RESOLUTE ONYX DES

RESOLUTE ONYX 2.0-mm DES: THE MOST DELIVERABLE DES1

Graph comparing average force of Resolute Onyx DES with competitor products.
Graphic showing that Resolute Onyx DES is engineered to expand from 2.0-mm to 3.25-mm.

ENGINEERED TO EXPAND

FROM 2.0–3.25 mm2:

  • Smallest DES expands from 2.0–3.25 mm
  • Low foreshortening when expanded to 3.25 mm3


Matrix showing the broadest DES sizes in the 2.0 to 5.0-mm range.

PROVEN CLINICAL PERFORMANCE

IN SMALL VESSELS:

  • 5% TLF, 2% TLR, and 0% stent thrombosis at 12 months in the RESOLUTE ONYX 2.0-mm Clinical Study4
  • Building on exceptional long-term safety and low event rates in the RESOLUTE Pooled small-vessel analysis in almost 4000 patients studied5

 

Close-up image of Resolute Onyx DES.
Image of physician working in the OR.

RESOLUTE ONYX 2.0-mm CLINICAL STUDY

EXCELLENT RESULTS IN SMALL VESSELS AT 12 MONTHS4

Graph depicting the rate of clinical events at 12 months with TLF and components.

EXCELLENT RESULTS IN RESOLUTE POOLED SMALL-VESSEL ANALYSIS AT 3 YEARS

PROVEN SMALL-VESSEL CLINICAL PERFORMANCE IN ALMOST 4000 PATIENTS STUDIED

Graph plotting percent of cumulative TLR incidence with time after initial procedure in months.
1

Bench test data on file at Medtronic. May not be indicative of clinical performance. Testing performed on smallest diameters available for Abbott Xience Alpine™*, Biotronik Orsiro™*, Boston Scientific Promus Premier™*, Boston Scientific Synergy™*, Medtronic Resolute Integrity™, and Medtronic Resolute Onyx™ coronary stents.

2

The Resolute Onyx stents should not be expanded to a diameter beyond the maximum labeled diameter listed on the label per the IFU. Do not dilate the 2.0- mm stents to greater than 3.25 mm. Postdilatation required for overexpansion.

3

Based on bench test data. May not be indicative of clinical performance.

4

Price et al. JACC Cardiovascular Interventions. 2017;10(14):1381–1388. Study only powered for TLF clinical endpoint. Rates are taken from KM estimates.

5

Serra et al. TCT 2014. Post-hoc RESOLUTE Pooled analysis was not powered for the analysis shown. RESOLUTE FIM, RESOLUTE All Comers, RESOLUTE International, RESOLUTE US, RESOLUTE US 38mm, RESOLUTE Japan, RESOLUTE China RCT, RESOLUTE China Registry, RESOLUTE Asia, RESOLUTE Japan SVS

© 2019 Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. ™* Third-party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company. For distribution in the USA only.